Live Breaking News & Updates on Allergopharma Gmbh|Page 2

Stay updated with breaking news from Allergopharma gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dermapharm Holding SE: Federal Minister of Health Jens Spahn joins opening ceremony for vaccine manu


Search jobs
30-Apr-2021
Dermapharm Holding SE: Federal Minister of Health Jens Spahn joins opening ceremony for vaccine manufacturing facility at subsidiary Allergopharma GmbH & Co. KG
DGAP-News: Dermapharm Holding SE
/ Key word(s): Miscellaneous
30.04.2021 / 13:00
The issuer is solely responsible for the content of this announcement.
Dermapharm Holding SE: Federal Minister of Health Jens Spahn joins opening ceremony for vaccine manufacturing facility at subsidiary Allergopharma GmbH & Co. KG
Grünwald, 30 April 2021 - Dermapharm Holding SE ( Dermapharm ), a rapidly growing manufacturer of branded pharmaceuticals, was joined today by Federal Minister of Health Jens Spahn, Minister-President Daniel Günther and Minister Dr Heiner Garg to mark the cooperation with BioNTech SE and the launch of production for the Comirnaty ....

Sachsen Anhalt , United States , Reinbek Schleswig Holstein , Biontech Comirnaty , Claudius Krause , Heiner Garg , Allergopharma Reinbek , Hans Georg Feldmeier , Britta Hamberger , Jens Spahn , Dermapharm Holding Se Key , Allergopharma Gmbh Co , Health Jens Spahn , Distribution Services , Dermapharm Holding Se , Dermapharm Holding , Investor Relations Corporate Communications , Federal Minister , Allergopharma Gmbh , Minister Dr Heiner Garg , Gmbh Arzneimittel , Federal Health Minister Jens , Corporate News , Regulatory Announcements , சாச்சேன் அன்ஹால்ட் , ஒன்றுபட்டது மாநிலங்களில் ,

Investegate |Dermapharm Holding SE Announcements | Dermapharm Holding SE: Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures


DGAP-News: Dermapharm Holding SE
/ Key word(s): Annual Results
Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures
13.04.2021 / 07:30
Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures
» Revenue and earnings up due to organic growth and successful acquisitions
» Vaccine production to commence in May 2021 at Allergopharma s site in Reinbek
» Consolidated revenue to grow by 24 % - 26 % in 2021
» Consolidated EBITDA to increase by 45 % - 50 % in 2021
» Dividend proposal of EUR 0.88 per share for 2020
Grünwald, 13 April 2021 - Dermapharm Holding SE ( Dermapharm ), a rapidly growing manufacturer of branded pharmaceuticals for selected therapeutic areas in Germany, today published its full Annual Report 2020. Dermapharm confirms its preliminary consolidated figures (IFRS) for financial year 2020. Both consolidated revenue and consolidated earnings continue on t ....

Sachsen Anhalt , Schleswig Holstein , Claudius Krause , Hans Georg Feldmeier , Britta Hamberger , Meeting Of Dermapharm Holding , Dermapharm Group , Allergopharma Gmbh Co , Dermapharm Holding Se , Dermapharm Holding , Investor Relations Corporate Communications , Annual Report , Allergopharma Gmbh , General Meeting , Annual General Meeting , Supervisory Board , Investegate Announcements , Investegate Company Announcements , Eqs And , சாச்சேன் அன்ஹால்ட் , ஸ்சிலேசுவிக் ஹோல்ஸ்டீன் , கிளாடியஸ் க்ராஸ் , முதலீட்டாளர் உறவுகள் பெருநிறுவன தகவல்தொடர்புகள் , ஆண்டு அறிக்கை , ஜநரல் சந்தித்தல் , ஆண்டு ஜநரல் சந்தித்தல் ,